16 Mar 2021 12:41
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 15 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,810,521 | 1.40% | 192,420 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
132,935 | 0.10% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
1,949,556 | 1.51% | 205,586 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 68 | 220.5064 USD |
Purchase | 100 | 220.7700 USD |
Purchase | 100 | 221.2075 USD |
Purchase | 100 | 219.5280 USD |
Purchase | 196 | 220.6391 USD |
Purchase | 200 | 220.4675 USD |
Purchase | 300 | 220.9166 USD |
Purchase | 922 | 220.5166 USD |
Purchase | 2,190 | 220.2567 USD |
Purchase | 4,416 | 220.8046 USD |
Purchase | 5,440 | 220.6921 USD |
Purchase | 11,122 | 221.2327 USD |
Purchase | 12,396 | 221.0392 USD |
Purchase | 13,784 | 220.4632 USD |
Purchase | 18,189 | 221.3500 USD |
Sale | 75 | 219.7500 USD |
Sale | 100 | 221.3600 USD |
Sale | 100 | 221.3700 USD |
Sale | 100 | 221.1795 USD |
Sale | 100 | 220.3900 USD |
Sale | 150 | 221.2940 USD |
Sale | 200 | 220.3850 USD |
Sale | 260 | 220.3784 USD |
Sale | 300 | 220.2466 USD |
Sale | 600 | 220.5083 USD |
Sale | 732 | 220.2697 USD |
Sale | 750 | 221.0900 USD |
Sale | 867 | 221.2723 USD |
Sale | 900 | 220.4261 USD |
Sale | 980 | 221.0514 USD |
Sale | 1,022 | 220.5414 USD |
Sale | 1,075 | 220.2686 USD |
Sale | 1,166 | 220.3914 USD |
Sale | 1,500 | 220.6170 USD |
Sale | 1,590 | 220.0388 USD |
Sale | 1,733 | 221.1784 USD |
Sale | 2,326 | 220.9318 USD |
Sale | 2,350 | 221.1822 USD |
Sale | 3,811 | 220.4479 USD |
Sale | 3,909 | 220.8839 USD |
Sale | 5,722 | 221.2586 USD |
Sale | 6,378 | 220.5076 USD |
Sale | 12,892 | 221.0025 USD |
Sale | 17,819 | 221.3500 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
|
| unit |
SWAP | Long | 1 | 373,335,970.0000 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 16 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005632/en/
Copyright Business Wire 2021